// App-Quantinova.ai

PO‐101 : Whole body magnetic resonance imaging (WB‐MRI) is more sensitive than 18F‐fluorodeoxyglucose positron emission tomography (18F‐FDG PET/CT) for baseline assessment of myeloma bone disease

Researchers

Presenter

  • I El-Najjar

Principal Investigators

  • A Panopoulou

  • O Westerland

  • S Natas

  • H Verma

  • G Milner

  • V Goh

  • M Streetly

Medical Centers

  • Hematology

  • Haematology, Guy's and St Thomas’ NHS Trust

  • Neuroimaging, Kings College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved